ARS Pharmaceuticals, Inc.’s Post

View organization page for ARS Pharmaceuticals, Inc., graphic

7,122 followers

#NEWS: We are excited to announce ARS Pharmaceuticals received FDA approval for neffy® (epinephrine nasal spray). This is the first and only epinephrine nasal delivery method approved and a key milestone in our mission to empower at-risk patients and caregivers. Learn more about the #FDAapproval here: https://bit.ly/3yoI4cP #biotechnews #biotech #science #innovation

Peter Karas

Chief Commercial Officer (CCO)

2mo

Congratulations

Angela Garnett

Operations Manager at Garnett Component Sales

2mo

Thrilled!!! When can we start getting these at our pharmacy?

Christine Creter

Strategist and Principal - Creter Group Inc.; Food Allergy and Eosinophilic Disorder Advocate

2mo

Congrats and thank you for working so hard to bring an alternative to a needle for delivery of epinephrine to our allergy community!!! As a parent of a teen that has 15 life threatening food allergies… I can say for certain that this is a game changer.

Chris Martinez MIB, CFRE

Chief Disruption Officer at The Asthma & Allergy Foundation of America -MidStates Chapter

2mo

Congratulations team! Your hard work has paid off and we are so excited about what this means for so many people, communities and schools. AND, we look forward to the opportunity to partner, especially in schools.

Sheri Stump

Senior Director Consumer Marketing, Treatment Resistant Depression at LivaNova

2mo

Congratulations! This is a tremendous step forward for those with severe allergies like my son. Thank you for the persistence and dedication in getting this advancement approved!

Emily Olson

Specialty Sales Representative 🔷 New Product Launches 🔷 Pharmaceutical Sales 🔷 Field-Based Account Management 🔷 Award-winner with strong clinical acumen and proven ability to exceed sales objectives

2mo

I am beyond ecstatic about this news!! I know so many families and friends who will benefit from neffy!! Way to go ARS Pharma!!

Beverly Savage

CEO, THE PHARMA RECRUITERS™ | Talent Acquisition | Consulting | Recruiting | Executive Leadership | Product Launch Teams | Expansion Teams | Sales & Business Development | Biotech | Pharmaceutical | Medical Device

2mo

Congratulations! As a former EpiPen District Manager who strongly advocated for patients, this is a game changer and great alternative for patients and caregivers to administer in an emergent situation. Kudos to ARS for being this needed product to market.

Amanda Thomas

PharmD | BCMTMS | Clinical Pharmacist | Collaborative Care | Well-Being Ambassador

2mo

Congratulations! As a pharmacist and long-time food allergy advocate, I have been eagerly awaiting this announcement! Celebrating with you!

Shameeka Hampton, B.S.

Highly Accomplished Field Reimbursement Manager with Expertise in Market Access, Buy-and-Bill, and Specialty Rx Therapeutics

2mo

This is amazing. As someone with a severe food allergy. I will be reaching out to my doctor. Hopefully, no more epi-pen. Congratulations.

Toni Fiorenza, MS. Ed.

Passionate Learning, Training & Development Leader

2mo

Congratulations! This will be a game changer.

See more comments

To view or add a comment, sign in

Explore topics